Response to Letter to Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”

Volume 26, Issue 12, December 2020, Pages e335-e336

Biology of Blood and Marrow Transplantation

Previous article in issueNext article in issue

Recommended articlesCiting articles (0)

© 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

Recommended articlesCiting articlesArticle Metrics

View original article

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

0 0 0 0 0 0 0

Comments (0)